Literature DB >> 29090981

Characterization of Unexpressed Extended-Spectrum Beta-Lactamase Genes in Antibiotic-Sensitive Klebsiella pneumoniae Isolates.

Zhao Zhang1, Yao Zhai1, Yatao Guo1, Daixi Li1, Zhanwei Wang2, Jing Wang3, Yusheng Chen4, Qi Wang5, Zhancheng Gao1.   

Abstract

OBJECTIVE: The current investigation explores whether extended-spectrum β-lactamase (ESBL) genes exist in clinical non-ESBL-producing Klebsiella pneumoniae isolates.
METHODS: A total of 202 clinical isolates with non-ESBL-producing K. pneumoniae were collected from southern and middle of China. Thirteen β-lactamase genes (blaSHV, CTX-M, TEM, OXA-2, OXA-10, VEB, PER, SFO, GES, CSP, TLA, BEL, and IBC) were screened by PCR and their identity confirmed by sequencing of PCR products. The ESBL-producing phenotype of the isolates that carried ESBL genes was tested and confirmed in 9 of the 18 isolates by a double-disc synergy test. The sequences upstream of ESBL genes of isolates with ESBL-producing genotype (+)/phenotype (-) were also subjected to PCR and sequencing. The ESBL genes and their upstream regions were cloned into Escherichia coli DH5α for functional evaluation.
RESULTS: A total of 8.9% (18/202) isolates carried ESBL genes. All of them harbored only one ESBL gene, including 33.3% (6/18) blaSHV and 66.7% (12/18) blaCTX-M. Among the isolates carrying ESBL genes, nine isolates were confirmed as ESBL phenotype (-). The ESBL genotype (+)/phenotype (-) isolates had blaSHV-27,38,41,42 (66.7%, 6/9) and blaCTX-M-3,15,24 (33.3%, 3/9). The upstream gene sequences, including promoters of these unexpressed ESBL genes, were intact without any mutations or spacers and effective among eight strains. The ISEcp1 element in the upstream region was not found in one isolate carrying an unexpressed blaCTX-M-15 gene.
CONCLUSIONS: Clinical non-ESBL-producing K. pneumoniae isolates could carry ESBL genes with intact promoter, but without the correlated phenotype. Specific silencing mechanisms may play an important role in regulating ESBL gene expression. This kind of isolates has the potential to transfer their ESBL genes to other bacteria with effective promoters, resulting in ESBL phenotype.

Entities:  

Keywords:  Klebsiella pneumoniae; antibiotic resistance silencing; non-extended-spectrum β-lactamases

Mesh:

Substances:

Year:  2017        PMID: 29090981     DOI: 10.1089/mdr.2017.0018

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  4 in total

1.  Phenotypic and Genotypic Characterization of ESBL-, AmpC-, and Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli Isolates.

Authors:  Hossein Kazemian; Hamid Heidari; Roya Ghanavati; Sobhan Ghafourian; Fateme Yazdani; Nourkhoda Sadeghifard; Hasan Valadbeigi; Abbas Maleki; Iraj Pakzad
Journal:  Med Princ Pract       Date:  2019-04-16       Impact factor: 1.927

2.  Cefixime and cefixime-clavulanate for screening and confirmation of extended-spectrum beta-lactamases in Escherichia coli.

Authors:  Mohammad Al-Tamimi; Hadeel Albalawi; Marwan Shalabi; Jumana Abu-Raideh; Ashraf I Khasawneh; Farah Alhaj
Journal:  Ann Clin Microbiol Antimicrob       Date:  2022-05-22       Impact factor: 6.781

3.  High prevalence of multiple antibiotic resistance in clinical E. coli isolates from Bangladesh and prediction of molecular resistance determinants using WGS of an XDR isolate.

Authors:  Preeti Jain; Asim Kumar Bepari; Prosengit Kumer Sen; Tanzir Rafe; Rashed Imtiaz; Maqsud Hossain; Hasan Mahmud Reza
Journal:  Sci Rep       Date:  2021-11-24       Impact factor: 4.379

4.  Large-scale genomic analysis of antimicrobial resistance in the zoonotic pathogen Streptococcus suis.

Authors:  Nazreen F Hadjirin; Eric L Miller; Gemma G R Murray; Phung L K Yen; Ho D Phuc; Thomas M Wileman; Juan Hernandez-Garcia; Susanna M Williamson; Julian Parkhill; Duncan J Maskell; Rui Zhou; Nahuel Fittipaldi; Marcelo Gottschalk; A W Dan Tucker; Ngo Thi Hoa; John J Welch; Lucy A Weinert
Journal:  BMC Biol       Date:  2021-09-07       Impact factor: 7.431

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.